Estados financieros detallados de Capricor Therapeutics, Inc. (CAPR): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $8.56, CAPR presenta beneficios negativos (P/E no significativo) y un ROE del -56.60%. La capitalización bursátil es de $492M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $3.2M | $2.7M | $1.7M | $1.0M | $310250 | $244898 | $2.6M | $25.2M | $22.3M | 0 |
| Coste de Ventas | $16.0M | 0 | 0 | $5.1M | 0 | 0 | $21.8M | $36.4M | $50.0M | 0 |
| Beneficio Bruto | -$12.9M | $2.7M | $1.7M | -$4.1M | $310250 | $244898 | -$19.3M | -$11.3M | -$27.7M | 0 |
| I+D | $16.0M | $10.8M | $12.1M | $5.1M | $8.5M | $13.6M | $21.8M | $36.4M | $50.0M | $84.5M |
| Generales y Administrativos | $4.9M | $4.8M | $4.9M | $3.6M | $5.5M | $7.6M | $10.4M | $12.8M | $14.9M | $22.7M |
| Gastos Operativos | $4.9M | $4.8M | $17.0M | $3.6M | $14.0M | $21.2M | $10.4M | $12.8M | $14.9M | $108.1M |
| Beneficio Operativo | -$17.0M | -$12.9M | -$15.3M | -$7.7M | -$13.7M | -$20.9M | -$29.7M | -$24.1M | -$42.6M | -$108.1M |
| EBITDA | -$18.3M | $3.0M | -$15.2M | -$7.6M | -$13.5M | -$19.8M | -$28.5M | -$21.2M | -$39.0M | -$100.1M |
| Gastos por Intereses | $344665 | $398807 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.0M |
| Beneficio Antes de Impuestos | -$18.8M | $2.4M | -$15.2M | -$7.6M | -$13.7M | -$20.0M | -$29.0M | -$22.3M | -$40.5M | -$105.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$18.8M | $2.4M | -$15.2M | -$7.6M | -$13.7M | -$20.0M | -$29.0M | -$22.3M | -$40.5M | -$105.0M |
| BPA | $-10.14 | $1.00 | $-5.17 | $-2.06 | $-0.88 | $-0.87 | $-1.18 | $-0.83 | $-1.15 | $-2.26 |
| BPA Diluido | $-10.14 | $0.90 | $-5.17 | $-2.06 | $-0.88 | $-0.87 | $-1.18 | $-0.83 | $-1.15 | $-2.26 |
| Acciones en Circulación (Diluidas) | $1.9M | $2.7M | $2.9M | $3.7M | $15.6M | $23.1M | $24.6M | $26.8M | $35.2M | $46.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$20.4M | 0 | 0 | 0 |
| Beneficio Operativo | -$26.3M | -$29.2M | -$36.8M | -$42.9M |
| EBITDA | -$24.1M | $976.2M | -$33.4M | $255.2M |
| Beneficio Neto | -$24.6M | -$30.2M | -$33.9M | -$40.7M |
| BPA | $-0.54 | $-0.62 | $-0.59 | $-0.70 |
| BPA Diluido | $-0.54 | $-0.62 | $-0.59 | $-0.70 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $3.2M | $6.1M | $4.3M | $3.9M | $32.7M | $34.9M | $9.6M | $14.7M | $11.3M | $287.8M |
| Inversiones a Corto | $13.0M | $8.0M | $3.0M | $6.0M | 0 | 0 | $31.8M | $24.8M | $140.2M | $30.3M |
| Cuentas por Cobrar | $223335 | $344575 | $204868 | $87968 | $56000 | $391750 | $547580 | $10.4M | $10.4M | $59167 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $18.1M | $15.7M | $8.5M | $10.5M | $33.7M | $36.4M | $42.9M | $50.9M | $163.4M | $322.9M |
| Inmovilizado Material | $435336 | $372096 | $574206 | $442806 | $850847 | $4.6M | $6.9M | $7.6M | $6.9M | $18.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $142253 | $93048 | $204868 | $6495 | $2165 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $18.7M | $16.3M | $9.2M | $11.1M | $34.6M | $41.3M | $50.1M | $58.7M | $170.5M | $355.9M |
| Cuentas por Pagar | $3.0M | $1.7M | $1.3M | $897992 | $2.7M | $3.7M | $4.8M | $6.2M | $3.3M | $1.7M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $246689 | $417632 | $682039 | $749112 | $834799 | $3.6M |
| Pasivos Corrientes | $4.9M | $1.7M | $1.3M | $897992 | $3.0M | $4.1M | $23.6M | $31.3M | $21.0M | $35.8M |
| Deuda a Largo | $17.0M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | 0 |
| Pasivos Totales | $22.8M | $5.0M | $4.6M | $4.3M | $6.4M | $10.0M | $38.3M | $36.1M | $25.0M | $50.2M |
| Reservas | -$54.0M | -$51.5M | -$66.7M | -$74.4M | -$88.0M | -$108.1M | -$137.1M | -$159.4M | -$199.8M | -$304.9M |
| Patrimonio Neto | -$4.0M | $11.2M | $4.6M | $6.8M | $28.2M | $31.4M | $11.8M | $22.6M | $145.5M | $305.8M |
| Deuda Total | $17.0M | $3.4M | $3.4M | $3.4M | $3.7M | $6.2M | $5.9M | $5.6M | $4.8M | $17.9M |
| Deuda Neta | $810969 | -$10.7M | -$3.9M | -$6.5M | -$29.0M | -$28.6M | -$35.5M | -$33.9M | -$146.7M | -$300.2M |
| Capital Circulante | $13.2M | $14.0M | $7.2M | $9.6M | $30.7M | $32.3M | $19.3M | $19.6M | $142.4M | $287.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $19.5M | $287.8M | $105.4M | $20.9M |
| Activos Totales | $126.4M | $355.9M | $326.3M | $368.7M |
| Pasivos Totales | $42.6M | $50.2M | $47.6M | $122.5M |
| Patrimonio Neto | $83.9M | $305.8M | $278.7M | $246.2M |
| Deuda Total | $17.9M | $17.9M | $21.1M | $91.0M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$18.8M | $2.4M | -$15.2M | -$7.6M | -$13.7M | -$20.0M | -$29.0M | -$22.3M | -$40.5M | -$105.0M |
| Amortizaciones | $125719 | $144174 | $157652 | $171956 | $143890 | $245697 | $533131 | $1.1M | $1.4M | $1.9M |
| Compensación en Acciones | $2.0M | $1.7M | $1.7M | $700984 | $2.0M | $3.0M | $4.5M | $7.4M | $9.8M | $17.2M |
| Cambio en Capital Circulante | -$583028 | -$2.9M | -$554588 | -$55344 | $1.5M | $182336 | $28.7M | -$11.8M | -$10.8M | $12.2M |
| Flujo de Caja Operativo | -$15.8M | -$14.2M | -$13.9M | -$6.8M | -$10.1M | -$16.8M | $4.9M | -$25.6M | -$40.0M | -$69.8M |
| Inversiones (CapEx) | -$193739 | -$32185 | -$316486 | 0 | -$547601 | -$1.2M | -$3.4M | -$2.0M | -$1.5M | -$2.9M |
| Adquisiciones | $1.8M | 0 | 0 | 0 | -$6.0M | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | -$193 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$16.0M | -$14.3M | -$14.2M | -$6.8M | -$10.6M | -$18.0M | $1.6M | -$27.6M | -$41.5M | -$72.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$19.7M | -$23.6M | -$29.3M | -$31.5M |
| Inversiones (CapEx) | -$4.0M | -$5.1M | -$10.7M | -$5.9M |
| Flujo de Caja Libre | -$23.7M | -$28.7M | -$40.0M | -$37.4M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $7.37B | -$3.39B | 0 | $9.58B |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -16.4% | -37.3% | -39.9% | -69.1% | -21.1% | +941.8% | +886.8% | -11.5% | -100.0% |
| Crecimiento Beneficio Neto (anual) | | +112.9% | -724.9% | +49.7% | -78.7% | -46.6% | -44.9% | +23.2% | -81.6% | -159.6% |
| Crecimiento BPA (anual) | | +109.9% | -617.0% | +60.2% | +57.3% | +1.1% | -35.6% | +29.7% | -38.6% | -96.5% |
| Cambio en Acciones (anual) | | +44.4% | +9.8% | +26.2% | +319.6% | +48.3% | +6.3% | +9.1% | +31.5% | +32.0% |
| Crecimiento FCF (anual) | | +10.8% | +0.6% | +51.9% | -55.4% | -69.8% | +108.6% | -1875.6% | -50.2% | -75.1% |
| Margen Bruto | -402.9% | 100.0% | 100.0% | -411.6% | 100.0% | 100.0% | -755.1% | -44.8% | -124.4% | |
| Margen Operativo | -532.2% | -482.4% | -917.2% | -769.5% | -4412.6% | -8549.9% | -1163.9% | -95.6% | -191.1% | |
| Margen EBITDA | -574.8% | 111.6% | -907.8% | -752.4% | -4366.2% | -8075.5% | -1116.5% | -84.3% | -175.3% | |
| Margen Neto | -589.6% | 91.2% | -909.1% | -760.4% | -4401.9% | -8175.9% | -1137.4% | -88.5% | -181.7% | |
| Margen FCF | -501.4% | -535.0% | -848.5% | -678.7% | -3417.4% | -7352.3% | 61.0% | -109.8% | -186.5% | |
| Tasa Impositiva Efectiva | -0.0% | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-8.62 | $-5.32 | $-4.82 | $-1.84 | $-0.68 | $-0.78 | $0.06 | $-1.03 | $-1.18 | $-1.56 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.9M | $2.3M | $2.9M | $3.7M | $15.6M | $23.1M | $24.6M | $26.8M | $35.2M | $46.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -56.60% |
| Rentabilidad sobre capital invertido | -40.08% |
| Rentabilidad sobre activos | -35.10% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.37 |
| Ratio corriente | 7.35 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -2.62 | 15.80 | -0.79 | -0.62 | -3.90 | -3.37 | -3.27 | -5.89 | -12.00 | -12.77 |
| P/VC | -12.33 | 3.26 | 2.61 | 0.69 | 1.89 | 2.16 | 8.04 | 5.79 | 3.34 | 4.39 |
| P/V | 15.47 | 13.74 | 7.21 | 4.73 | 172.15 | 276.24 | 37.15 | 5.20 | 21.82 | 0.00 |
| Margen Bruto | -402.9% | 100.0% | 100.0% | -411.6% | 100.0% | 100.0% | -755.1% | -44.8% | -124.4% | 0.0% |
| Margen Operativo | -532.2% | -482.4% | -917.2% | -769.5% | -4412.6% | -8549.9% | -1163.9% | -95.6% | -191.1% | 0.0% |
| Margen Neto | -589.6% | 91.2% | -909.1% | -760.4% | -4401.9% | -8175.9% | -1137.4% | -88.5% | -181.7% | 0.0% |